A new Yale study has found a promising target for treating the brain fog that can follow COVID-19 and offers new insight into ...

The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest with recent years witnessing several important controversies.

CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: BIIB) today announced upcoming scientific presentations at the 2025 Alzheimer’s Association International Conference (AAIC), taking place ...

Women are nearly twice as likely as men to develop Alzheimer’s disease, a disparity that can’t be fully explained by ...

A neglected piece of the Alzheimer's puzzle has been getting increased scientific attention: why women are twice as likely as ...

Sleep is essential for our survival—just like food and water. Yet, almost two out of three people in the US don’t get enough sleep. One-third sleep six hours or less, double the rate from ...

Nanoparticles (NPs) are materials whose dimensions range from 1 to 1,000 nanometers (nm). Due to their nano-scale dimensions and tunable material properties, NPs have gained interest in the global ...

PPIs may also lead to an increase in the formation of the protein beta-amyloid, which is linked to Alzheimer ... without a ...

However, a new study suggests a different cause. The research team found that Alzheimer’s may be linked to problems with the ...

Scientists at the Institute for Basic Science (IBS) in South Korea have discovered a new enzyme, called SIRT2, that may play ...

Emerging research positions TUDCA, a bile acid compound, as a promising neuroprotective agent against Alzheimer’s, ...

Amyloid precursor protein (APP)-derived amyloid-β (Aβ) peptides form pathological aggregates in Alzheimer’s disease (AD).